Total Payments
$237,098
2024 Payments
$21,611
Companies
23
Transactions
249
Medicare Patients
25,682
Medicare Billing
$1.1M
Payment Breakdown by Category
Consulting$207,696 (87.6%)
Food & Beverage$13,262 (5.6%)
Other$8,242 (3.5%)
Travel$7,893 (3.3%)
Education$4.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $207,696 | 45 | 87.6% |
| Food and Beverage | $13,262 | 171 | 5.6% |
| Travel and Lodging | $7,893 | 26 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,742 | 4 | 2.8% |
| Honoraria | $1,500 | 1 | 0.6% |
| Education | $4.80 | 1 | 0.0% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$237,098
248 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $152,470 | 42 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $24,110 | 12 | $0 (2024) |
| CVRx, Inc. | $21,527 | 11 | $0 (2022) |
| Boston Scientific Corporation | $14,415 | 34 | $0 (2024) |
| AltaThera Pharmaceuticals LLC | $7,508 | 3 | $0 (2024) |
| Medtronic, Inc. | $6,521 | 21 | $0 (2024) |
| Preventice Services, LLC | $3,433 | 3 | $0 (2021) |
| PFIZER INC. | $2,193 | 15 | $0 (2024) |
| Aziyo Biologics, Inc. | $1,627 | 6 | $0 (2017) |
| Medtronic Vascular, Inc. | $1,517 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,611 | 56 | Boston Scientific Corporation ($6,670) |
| 2023 | $36,344 | 46 | Abbott Laboratories ($26,006) |
| 2022 | $49,255 | 30 | Abbott Laboratories ($40,824) |
| 2021 | $105,496 | 31 | Abbott Laboratories ($76,236) |
| 2020 | $14,414 | 16 | CVRx, Inc. ($9,758) |
| 2019 | $794.93 | 30 | Abbott Laboratories ($165.66) |
| 2018 | $43.64 | 3 | Janssen Pharmaceuticals, Inc ($43.64) |
| 2017 | $9,137 | 37 | Abbott Laboratories ($4,356) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,613.00 | General |
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $118.07 | General |
| 12/06/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $77.82 | General |
| 12/06/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $13.18 | General |
| 12/06/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $7.52 | General |
| 12/05/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $77.13 | General |
| 12/05/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $77.13 | General |
| 12/05/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $39.63 | General |
| 12/04/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $102.43 | General |
| 12/04/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $68.52 | General |
| 12/03/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $189.00 | General |
| 12/03/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $28.40 | General |
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Cardiovascular | ||||||
| 11/04/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $726.95 | General |
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.27 | General |
| Category: Cardiovascular | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: General - Therapies_CRM | ||||||
| 09/19/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: General - Therapies_CRM | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $0.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: Cardiovascular | ||||||
| 08/08/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $605.24 | General |
| Category: General - Therapies_CRM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 7,226 | 12,247 | $1.5M | $309,731 |
| 2022 | 31 | 7,678 | 12,052 | $1.5M | $315,216 |
| 2021 | 28 | 5,046 | 7,467 | $1.1M | $262,948 |
| 2020 | 31 | 5,732 | 8,035 | $1.1M | $227,751 |
Total Patients
25,682
Total Services
39,801
Medicare Billing
$1.1M
Procedure Codes
132
All Medicare Procedures & Services
132 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 570 | 917 | $339,290 | $80,194 | 23.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 2,065 | 2,918 | $213,014 | $29,807 | 14.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 496 | 1,323 | $125,685 | $22,721 | 18.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 242 | 369 | $97,677 | $21,991 | 22.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 2,279 | 3,467 | $121,345 | $20,892 | 17.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 319 | 855 | $97,470 | $19,125 | 19.6% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 54 | 264 | $25,872 | $14,936 | 57.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 86 | 97 | $48,112 | $13,457 | 28.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 177 | 470 | $106,220 | $12,810 | 12.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 85 | 127 | $45,085 | $12,061 | 26.8% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 63 | 107 | $41,411 | $7,763 | 18.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 55 | $38,005 | $7,517 | 19.8% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 142 | 367 | $33,397 | $7,212 | 21.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 42 | 42 | $29,610 | $6,791 | 22.9% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 59 | 90 | $25,920 | $6,465 | 24.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 32 | 241 | $21,931 | $4,708 | 21.5% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 43 | 68 | $15,474 | $3,538 | 22.9% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 66 | 75 | $11,325 | $3,274 | 28.9% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 29 | 47 | $11,186 | $3,102 | 27.7% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 30 | 44 | $8,316 | $2,213 | 26.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $6,084 | $1,351 | 22.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 21 | $5,229 | $1,326 | 25.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 14 | $5,124 | $1,280 | 25.0% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 17 | 20 | $4,295 | $1,081 | 25.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 42 | 43 | $3,870 | $844.91 | 21.8% |
About Dr. Thomas Deering, MD
Dr. Thomas Deering, MD is a Cardiovascular Disease healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932104239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Deering, MD has received a total of $237,098 in payments from pharmaceutical and medical device companies, with $21,611 received in 2024. These payments were reported across 249 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($207,696).
As a Medicare-enrolled provider, Deering has provided services to 25,682 Medicare beneficiaries, totaling 39,801 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 132 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Atlanta, GA
- Active Since 06/15/2005
- Last Updated 09/20/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1932104239
Products in Payments
- EP-4 (Device) $68,719
- FlexAbility Ablation Catheter (Device) $44,731
- EP-4 Cardiac Stimulator (Device) $33,894
- MULTAQ (Drug) $24,110
- Barostim Neo System (Device) $21,527
- Sotalol Hydrochloride (Drug) $7,508
- CRM-Research only (Device) $3,543
- ELIQUIS (Drug) $2,240
- WATCHMAN (Device) $1,758
- ECM Patch (Device) $1,627
- BG Mini Plus (Device) $1,508
- XARELTO (Drug) $411.98
- Cardiovascular-Research only (Device) $383.00
- MRI Ready Leads (Device) $333.28
- ENTRESTO (Drug) $207.76
- LUX-Dx Insertable Cardiac Monitor (Device) $198.90
- BodyGuardian (Device) $189.57
- AMPLATZER AMULET (Device) $171.05
- General - Therapies (Device) $168.74
- Mitra Clip system (Device) $165.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Atlanta
David Kandzari, Md, MD
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
William Nicholson, Md, MD
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Joseph Miller, Md, MD
Cardiovascular Disease — Payments: $767,251
Cardiovascular Disease $767,251
Adam Greenbaum, M.d, M.D
Cardiovascular Disease — Payments: $377,582
Cardiovascular Disease $377,582
Randolph Martin, Md, MD
Cardiovascular Disease — Payments: $358,457
Cardiovascular Disease $358,457
Mani Vannan, Mbbs, MBBS
Cardiovascular Disease — Payments: $234,877
Cardiovascular Disease $234,877